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Introduction
Maintenance of genetic stability requires faithful segregation of 
duplicated chromosomes during mitosis. Most human cancers 
consist of cells that have an abnormal chromosome content, 
which is also known as aneuploidy. However, how the aneu-
ploidy develops remains poorly understood (Jallepalli and Len-
gauer, 2001; Draviam et al., 2004; Weaver and Cleveland, 2005). 
The spindle assembly checkpoint, commonly referred to as the 
mitotic checkpoint, is a surveillance mechanism that ensures 
  accurate segregation of mitotic chromosomes by delaying 
  metaphase-to-anaphase progression until each kinetochore has 
properly attached to the mitotic spindle (Kops et al., 2005). 
  Kinetochores that are not yet attached to mitotic microtubules 
and chromosome pairs that lack tension across sister chromatids 
generated by the spindle poles activate the spindle assembly 
checkpoint (Yu, 2002; Rieder and Maiato, 2004). Various mitotic 
checkpoint proteins, including Bub3, Bub1, BubR1, Mad1, and 
Mad2, bind to kinetochores that lack attachment or tension and 
generate a “stop anaphase” signal that diffuses into the mitotic 
cytosol (Shah and Cleveland, 2000). This signal is believed to 
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consist of Bub3, BubR1, and Mad2 protein complexes (Fang 
et al., 1998; Sudakin et al., 2001; Tang et al., 2001). These com-
plexes bind to Cdc20 to prevent premature ubiquitination of 
  cyclin B and securin by the anaphase-promoting complex (APC; 
Peters, 2002; Nasmyth and Haering, 2005). Checkpoint inactiva-
tion occurs after proper alignment of the mitotic chromosomes at 
the metaphase plate. This triggers release of Bub3, BubR1, and 
Mad2 protein complexes from Cdc20 and subsequent destruction 
of cyclin B and securin by the APC. Separase, which in mam-
malian cells is inhibited through association with securin and 
also by cyclin B/Cdk1-mediated phosphorylation, triggers sis-
ter chromatid disjunction by cleavage of the cohesin subunit 
Scc1 (Nasmyth and Haering, 2005). Various studies have ad-
dressed the physiological relevance of the spindle assembly 
checkpoint by deleting Mad or Bub genes in the mouse (for re-
view see Baker et al., 2005). Mice that are homozygous null for 
Mad2, Bub3, or BubR1 die during the early stages of embryo-
genesis (Dobles et al., 2000; Kalitsis et al., 2000; Babu et al., 
2003; Baker et al., 2004; Wang et al., 2004), with a small subset 
of Mad2-null embryos remaining viable until embryonic day 10.5 
(Burds et al., 2005). On the other hand, mice that are heterozygous 
null for these genes are born alive and seem to exhibit no overt 
phenotypes. Thus, the challenge for studying the function of indi-
vidual mitotic checkpoint genes in the mouse is to disrupt their 
function signifi  cantly but not so severely that the embryo dies.
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A
ging is a highly complex biological process that 
is believed to involve multiple mechanisms. Mice 
that have small amounts of the mitotic checkpoint 
protein BubR1 age much faster than normal mice, but 
whether other mitotic checkpoint genes function to prevent 
the early onset of aging is unknown. In this study, we show 
that several aging-associated phenotypes appear early in 
mice that are double haploinsufﬁ   cient for the mitotic 
checkpoint genes Bub3 and Rae1 but not in mice that are 
single haploinsufﬁ  cient for these genes. Mouse embryonic 
ﬁ  broblasts (MEFs) from Bub3/Rae1 haploinsufﬁ  cient mice 
undergo premature senescence and accumulate high lev-
els of p19, p53, p21, and p16, whereas MEFs from single 
haploinsufﬁ   cient mice do not. Furthermore, although 
BubR1 hypomorphic mice have less aneuploidy than 
Bub3/Rae1 haploinsufﬁ  cient mice, they age much faster. 
Our ﬁ  ndings suggest that early onset of aging-associated 
phenotypes in mice with mitotic checkpoint gene defects 
is linked to cellular senescence and activation of the p53 
and p16 pathways rather than to aneuploidy.JCB • VOLUME 172 • NUMBER 4 • 2006  530
Recently, we have reported the generation of a series 
of mice in which the expression of BubR1 is reduced in a 
graded fashion from normal levels to zero by the use of wild-
type, knockout, and hypomorphic alleles (Baker et al., 2004). 
Of this series, mice with BubR1 levels as low as 10% of nor-
mal (BubR1
H/H mice) are born alive and develop into adult 
mice. Remarkably, despite having severe aneuploidy, these 
animals do not have an escalated spontaneous tumor burden 
(Baker et al., 2004). Instead, these mice develop a variety of 
progeroid (resembling old age) features. In addition, mouse 
embryonic fi   broblasts (MEFs) from BubR1
H/H mice show 
profound premature cellular senescence. These observations, 
combined with the demonstration that BubR1 levels decline 
in ovary, testis, and spleen tissue as wild-type mice age, have 
suggested that this mitotic checkpoint protein is a key regula-
tor of the normal aging process. However, whether aging is a 
general feature of spindle assembly checkpoint dysfunction 
remains unknown.
The mitotic checkpoint protein Bub3 is a seven-blade 
β propeller that has substantial sequence similarity with the mRNA 
export factor protein Rae1; the two proteins have 34% identity 
and 52% similarity in humans (Larsen and Harrison, 2004). 
Like Bub3 (Kalitsis et al., 2000), Rae1 is essential for early 
mouse embryogenesis, but mice that are haploinsuffi  cient for 
Bub3 or Rae1 are viable and have a normal appearance (Babu 
et al., 2003). These heterozygous mice show remarkably similar 
mitotic defects, including spindle assembly checkpoint impair-
ment and chromosome missegregation (Babu et al., 2003). Mice 
that are haploinsuffi  cient for both Bub3 and Rae1 are also via-
ble but develop much more severe mitotic phenotypes than sin-
gle haploinsuffi  cient mice. In this study, we have investigated 
the long-term phenotypes of mice in which the mitotic check-
point proteins Bub3 and Rae1 are disrupted individually or in 
combination. We fi  nd that phenotypes associated with aging 
  appear early in double haploinsuffi  cient mice but not in single 
haploinsuffi  cient mice. We also fi  nd that single and double hap-
loinsuffi  cient mice are not predisposed to spontaneous tumor 
development despite the accumulation of substantial numbers 
of aneuploid cells.
Results
Combined Bub3 and Rae1 
haploinsufﬁ  ciency reduces lifespan
To examine the long-term biological consequences of impaired 
spindle assembly checkpoint function, we generated cohorts of 
mice in which the mitotic checkpoint genes Bub3 and Rae1 were 
haploinsuffi  cient individually or in combination (Babu et al., 
2003). We monitored 70 wild-type, 56 Bub3
+/–, 96 Rae1
+/–, 
and 100 Bub3
+/–/Rae1
+/– mice daily for spontaneous tumor 
  development or ill health for a period of >2 yr. During the fi  rst 
Figure 1.  Combined Bub3 and Rae1 haploinsufﬁ  ciency reduces lifespan. 
(A–D) Representative photographs of wild-type and Bub3
+/–/Rae1
+/– mice 
at 5 (A and B) and 27 mo (C and D). These animals were not moribund at 
the time of the picture. Note the overt cataract, severe lordokyphosis, and 
cachetic appearance of the 27-mo-old Bub3
+/–/Rae1
+/– mouse pictured 
in D. (E) Overall survival curves for wild-type, Bub3
+/–, Rae1
+/–, and 
Bub3
+/–/Rae1
+/– mice. The curve marked with an asterisk is signiﬁ  cantly 
different from that of wild-type mice using a log-rank test. We note that the 
lifespan of Bub3
+/– and Rae1
+/– mice is not statistically different from that 
of Bub3
+/–/Rae1
+/– mice.
Figure 2. Bub3
+/−/Rae1
+/− mice develop spontaneous tumors at normal 
rates despite severe aneuploidy. (A) Spontaneous tumor incidence, 
  latency, and spectrum of wild-type and Bub3
+/–/Rae1
+/– mice. Upon 
biopsy of moribund animals, all tissues were screened for tumors. 
  Tumorous tissues were collected and processed for histological evalua-
tion. (B) Tumor-free survival curves of wild-type, Bub3
+/–, Rae1
+/–, and 
Bub3
+/–/Rae1
+/– mice.SPINDLE ASSEMBLY CHECKPOINT GENE DEFECTS AND AGING • BAKER ET AL. 531
year of life, Bub3
+/–/Rae1
+/–, Bub3
+/–, and Rae1
+/– mice were 
indistinguishable from wild-type mice and exhibited no overt 
abnormalities (Fig. 1, A and B; and not depicted).   However, 
in the second year, a substantial proportion of Bub3
+/–/
Rae1
+/– mice began to develop an aged appearance (Fig. 1 D). 
Wild-type mice did not show this appearance (Fig. 1 C), nor 
did Bub3
+/– or Rae1
+/– mice. The median overall survival of 
Bub3
+/– and Rae1
+/– mice was slightly reduced in comparison 
with wild-type animals (24 vs. 25 mo, respectively), but these 
differences were not signifi  cant (Fig. 1 E). In contrast, the me-
dian survival of Bub3
+/–/Rae1
+/– mice was signifi  cantly reduced 
to 22 mo, which translates into a 12% decrease in lifespan. 
We note that the reduced lifespan of Bub3
+/–/Rae1
+/– mice may 
be the result of the sum of the lifespan reductions in Bub3
+/– and 
Rae1
+/– mice.
Spontaneous tumorigenesis is not 
accelerated in Bub3
+/−/Rae1
+/− mice despite 
high aneuploidy
We performed biopsies on moribund mice from our cohorts to 
investigate whether chromosome number instability predis-
poses mice to spontaneous tumorigenesis. The tumor incidences 
of Bub3
+/–, Rae1
+/–, and Bub3
+/–/Rae1
+/– mice were not signifi  -
cantly different from wild-type mice (Fig. 2 A). In addition, the 
tumor spectra exhibited in these groups were nearly identical. 
Comparison of the tumor-free survival curves of the various ge-
notypes revealed a slight decrease in tumor latency in Bub3
+/–/
Rae1
+/– mice compared with wild-type mice; however, this de-
crease is not signifi  cant (Fig. 2 B). The observed slight reduc-
tion in tumor latency most likely relates to the lifespan reduction 
of  3 mo in the Bub3
+/–/Rae1
+/– group. This difference is mir-
rored by the reduction in tumor latency by  4 mo. Thus, mice 
in which the mitotic checkpoint genes Bub3 and Rae1 are dis-
rupted individually or in combination are not predisposed to 
spontaneous tumorigenesis.
Aneuploidy progresses with age in mice 
with various mitotic checkpoint 
gene defects
Chromosome counts on splenocytes from 5-mo-old mice have 
shown that Bub3 and Rae1 single heterozygotes have signifi  -
cant numbers of aneuploid cells and that combined heterozy-
gosity dramatically increases these numbers (Table I; Babu 
et al., 2003). We sought to determine whether an  euploidy pro-
gressed with age in Bub3
+/–, Rae1
+/–, and Bub3
+/–/Rae1
+/– mice. 
Indeed, aneuploidy in single haploinsuffi  cient Bub3 and Rae1 
mice increased dramatically over time. Specifi  cally, the aneu-
ploidy in Bub3
+/– splenocytes increased from 9% at 5 mo to 
29% at 27 mo, whereas in Rae1
+/– splenocytes, it increased 
from 9% at 5 mo to 33% at 24 mo (Table I). In splenocytes of 
Bub3
+/–/Rae1
+/– mice, aneuploidy was already 37% at 5 mo of 
age but further increased by 10% over the next 19 mo. Wild-
type mice had no aneuploidy at 27 mo, but 3% aneuploidy was 
detected at 35 mo. Aside from aneuploidy, another feature of 
defective or weakened spindle assembly checkpoint activity in 
mice is premature sister chromatid separation (PMSCS; Michel 
et al., 2001; Baker et al., 2004). Mitotic fi  gures from Bub3 and 
Rae1 single heterozygotes showed no PMSCS at 5 mo, but 
10–11% of metaphases examined at 24–27 mo displayed this 
feature. As Bub3
+/–/Rae1
+/– mice aged, the percentage of cells 
exhibiting PMSCS also increased (Table I), going from 14% at 
5 mo to 24% at 24 mo. The increases in PMSCS in Bub3
+/–, 
Rae1
+/–, and Bub3
+/–/Rae1
+/– mice suggest that the activity 
of the spindle assembly checkpoint further declines as these 
  animals age. Splenocytes from wild-type mice displayed no 
  PMSCS at 27 mo, but 4% of splenocytes had PMSCS at 35 mo, 
suggesting that checkpoint activity declines as normal mice 
reach an extremely old age. We observed no chromosome breaks 
or fusions in metaphase spreads from 27-mo-old wild-type and 
24-mo-old Bub3
+/–, Rae1
+/–, and Bub3
+/–/Rae1
+/– mice (Table I). 
Thus, aneuploidy and PMSCS progress as mice in which Bub3 
Table I. Mice that are single or double haploinsufﬁ  cient for Bub3 and Rae1 develop progressive aneuploidy
Mouse genotype Age (n) Mitotic
ﬁ  gures 
inspected
Percent 
aneuploid 
ﬁ  gures (SD)
Karyotypes with indicated chromosome number Percent 
mitotic 
ﬁ  gures with 
PMSCS (SD)
Percent 
mitotic 
ﬁ  gures with
breaks
Percent
mitotic 
ﬁ  gures with 
fusions
37 38 39 40 41 42 43 44 45 46 47
Wild type 5 mo (3) 150 0 (0) 150 0 (0) ND ND
22 mo (3) 150 0 (0) 150 0 (0) ND ND
27 mo (3) 150 0 (0) 150 0 (0) 0 0
35 mo (3) 150 3 (1) 1 145 3 1 4 (1) ND ND
Bub3
+/− 5 mo (3) 150 9 (1) 2 3 136 7 2 0 (0) ND ND
27 mo (3) 150 29 (3) 2 3 5 106 20 9 5 11 (2) 0 0
Rae1
+/− 5 mo (3) 150 9 (1) 3 2 136 6 3 0 (0) ND ND
24 mo (3) 150 33 (5) 1 5 10 101 19 9 2 3 10 (2) 0 0
Bub3
+/−/Rae1
+/− 5 mo (4) 200 36 (2) 6 9 9 128 8 16 10 6 5 3 14 (1) ND ND
12 mo (3) 150 39 (3) 4 5 8 92 9 11 11 6 1 1 2 18 (2) ND ND
18 mo (3) 150 45 (2) 5 9 6 83 11 8 17 3 4 2 2 22 (2) ND ND
24 mo (3) 150 47 (1) 8 6 8 80 12 16 7 8 2 1 2 24 (5) 0 0
BubR1
H/H 5 mo (4) 200 15 (4) 2 12 170 16 35 (4) ND ND
12 mo (5) 250 33 (4) 9 22 168 44 7 24 (4) ND ND
Empty spaces mean that there were no karyotypes with the indicated chromosome number.JCB • VOLUME 172 • NUMBER 4 • 2006  532
and Rae1 are disrupted individually or in combination age. 
  Furthermore, mild aneuploidy and PMSCS are features of very 
old wild-type mice.
Bub3
+/−/Rae1
+/− mice display early 
aging–associated phenotypes
The fi  nding that several Bub3
+/–/Rae1
+/– mice displayed an 
aged appearance at a relatively young age prompted us to 
screen for aging-associated phenotypes in a systematic fashion. 
All mice of our cohort were screened every 2 wk for the devel-
opment of cataracts and lordokyphosis (abnormal convexity in 
the curvature of the spine when viewed from the side). This 
monitoring strategy revealed that the incidence of cataract for-
mation was signifi  cantly higher in Bub3
+/–/Rae1
+/– mice than in 
Bub3
+/–, Rae1
+/–, and wild-type mice (Fig. 3 A). Furthermore, 
the latency of cataract formation was shorter in Bub3
+/–/Rae1
+/– 
mice than in mice of the other genotypes. Histological examina-
tion confi  rmed that cataractous eyes from Bub3
+/–/Rae1
+/– mice 
had features reminiscent of human age–related cataracts (Fig. 3, 
B and C). Bub3
+/–/Rae1
+/– mice developed lordokyphosis at an 
earlier age and with greater severity than Bub3
+/–, Rae1
+/–, and 
wild-type mice (Fig. 4, A and B). Mutant mice with early lor-
dokyphosis, but not age-matched control animals, showed clear 
signs of skeletal muscle atrophy and degeneration (Fig. 4 C).
We next screened for additional aging-associated pheno-
types by comparative analysis of mice from our Bub3
+/–/
Rae1
+/– and wild-type cohorts. A well-established feature of ag-
ing is loss of body weight (MacIntosh et al., 2000). Although 
the weight of Bub3
+/–/Rae1
+/– mice at 5 mo was similar to that 
of age-matched wild-type mice, Bub3
+/–/Rae1
+/– mice had 
 signifi  cantly lower body mass than wild-type mice at 24 mo 
(Fig. 5 A). Dual energy X-ray absorptiometry was used to deter-
mine whether this loss of weight was caused by a reduction in 
total body fat. At 5 mo of age, Bub3
+/–/Rae1
+/– and wild-type 
mice had similar percentages of total body adipose tissue; how-
ever, at 27 mo, Bub3
+/–/Rae1
+/– showed a dramatic reduction in 
body fat compared with wild-type mice (Fig. 5 B). Reduced 
dermal thickness and subdermal adipose are characteristics of 
aged mice (de Boer et al., 2002; Tyner et al., 2002). Histological 
examination of the skin revealed signifi  cant reductions in sub-
cutaneous adipose thickness in 27-mo-old Bub3
+/–/Rae1
+/– mice 
but not in age-matched control animals (Fig. 5, C and E). The 
mean dermal thickness of 27-mo-old Bub3
+/–/Rae1
+/– mice was 
21% lower than that of 5-mo-old Bub3
+/–/Rae1
+/– mice (Fig. 
5 D), whereas in 27-mo-old wild-type mice, it was only 9% 
lower than in 5-mo-old wild-type mice (Fig. 5 D).
We then investigated whether the age-related phenotypes 
present in Bub3
+/–/Rae1
+/– mice could also be observed in very 
old wild-type mice. We found that wild-type mice of 35 mo had 
lordokyphosis (Fig. 4 B), muscle atrophy (Fig. 4 C), and osteo-
porosis (not depicted). These mice also had signifi  cantly lower 
amounts of total body fat and subcutaneous adipose tissue than 
5-mo-old wild-type mice (Fig. 5, B and C). As expected, the 
dermis of 35-mo-old wild-type mice was signifi  cantly thinner 
Figure 3.  Combined Bub3 and Rae1 haploinsufﬁ  ciency  accelerates 
  cataract formation. (A) Cataract incidence of wild-type, Bub3
+/–, Rae1
+/–, and 
Bub3
+/–/Rae1
+/– mice as detected by the use of slit light after dilating the 
eyes. The asterisk indicates that the curve is statistically different from that 
of wild-type mice using a log-rank test. (B) Overt cataract detected in a 
15-mo-old Bub3
+/–/Rae1
+/– mouse. (C) Cross section of a cataractous lens 
from a 15-mo-old Bub3
+/–/Rae1
+/– mouse stained with hematoxylin and 
eosin. Note that the posterior portion of the eye has Morgagnian globules, 
whereas the inner portion has profound calciﬁ  cation. Bar, 1 mm.
Figure 4.  Lordokyphosis develops early in mice with combined Bub3 and 
Rae1 haploinsufﬁ  ciency.  (A) Incidence of lordokyphosis in wild-type, 
Bub3
+/–, Rae1
+/–, and Bub3
+/–/Rae1
+/– mice. The asterisk indicates that 
the curve is statistically different from that of wild-type mice using a log-rank 
test. (B) Skinned 19-mo-old Bub3
+/–/Rae1
+/–, 19-mo-old wild-type, and 
35-mo-old wild-type mice. The Bub3
+/–/Rae1
+/– mouse and the 35-mo-old 
wild-type mouse exhibit lordokyphosis (arrowheads) and have little subcu-
taneous fat (arrows). (C) Cross section of gastrocnemius muscles of the ani-
mals shown in B. Arrowheads mark degenerated ﬁ  bers, and arrows mark 
areas of ﬁ  broblast inﬁ  ltration.SPINDLE ASSEMBLY CHECKPOINT GENE DEFECTS AND AGING • BAKER ET AL. 533
than that of 5-mo-old wild-type mice (Fig. 5 D). Together, the 
aforementioned data show that several aging-associated pheno-
types appear early in mice that are double haploinsuffi  cient for 
the mitotic checkpoint genes Bub3 and Rae1 but not in mice 
that are single haploinsuffi  cient for these genes. The data also 
show that most of these phenotypes do occur in wild-type mice 
of extremely advanced age.
Combined haploinsufﬁ  ciency of Bub3 
and Rae1 results in premature senescence
We next investigated whether combined haploinsuffi  ciency of 
Bub3 and Rae1 triggers cell death or cellular senescence, which 
are two processes that have been linked to aging (Campisi, 
2005; Lombard et al., 2005). We intercrossed Bub3
+/– and 
Rae1
+/– mice to produce Bub3
+/–/Rae1
+/–, Bub3
+/–, Rae1
+/–, and 
wild-type MEFs from 13.5-d-old fetuses. At passage 5 (P5), we 
assayed Bub3
+/–/Rae1
+/– and wild-type MEFs for cell death by 
TUNEL staining. We observed no difference in amounts of 
  TUNEL-positive cells in Bub3
+/–/Rae1
+/– and wild-type MEFs 
cultures (Fig. 6 A), indicating that combined haploinsuffi  ciency 
of Bub3 and Rae1 did not increase the rate of cell death. 
  Combined annexin V–FITC and propidium iodide (PI) staining 
of P5 Bub3
+/–/Rae1
+/– and wild-type MEFs showed that neither 
apoptotic nor nonapoptotic cell death was signifi  cantly increased 
in Bub3
+/–/Rae1
+/– MEFs (Fig. 6 B) despite high rates of chro-
mosome missegregation in mitosis. This is remarkable because 
high rates of cell death have been observed in studies in which 
the mitotic checkpoint proteins Mad2 and BubR1 were depleted 
by short inhibitory RNA (Kops et al., 2004; Meraldi et al., 2004; 
Michel et al., 2004). Thus, it seems that cell death only occurs 
when mitotic checkpoint proteins drop below a critical thresh-
old level and that aberrant chromosome segregation itself is in-
suffi  cient to trigger cell death.
Cellular senescence is characterized in vitro by a decline 
in growth rate (Atadja et al., 1995). At P3, Bub3
+/–/Rae1
+/– 
growth rates were similar to those of Bub3
+/–, Rae1
+/–, and 
wild-type MEFs (Fig. 6 C). On the other hand, at P7, Bub3
+/–/
Rae1
+/– MEFs showed signifi   cantly reduced growth rates 
Figure 5.  Early aging–related phenotypes of 
combined Bub3/Rae1 haploinsufﬁ  cient  mice. 
(A) Body weight analysis of wild-type and 
Bub3
+/–/Rae1
+/– male mice (n ≥ 4 male mice 
per genotype). Bub3
+/–/Rae1
+/– mice have 
normal body weights at 5 mo but signiﬁ  cantly 
reduced body weights at 24 mo. We note that 
neither Bub3
+/– nor Rae1
+/– mice show this re-
duction (not depicted). The decrease in body 
weight between the 24- and 35-mo-old wild-
type mice is not signiﬁ  cant but does show a 
trend of reduction in body weight. (B) Graph 
showing total body fat content in wild-type and 
Bub3
+/–/Rae1
+/– mice at 5, 27, and 35 mo 
(n = 4 male mice per genotype at each age). 
(C) Graph showing subcutaneous adipose 
layer thickness of wild-type and Bub3
+/–/
Rae1
+/– mice at 5 and 27 mo along with 35-
mo-old wild-type mice. Note the reduced thick-
ness in 27-mo-old Bub3
+/–/Rae1
+/– mice and 
35-mo-old wild-type mice (n = 4 males per ge-
notype). (D) Graph showing dermal thickness 
of wild-type and Bub3
+/–/Rae1
+/– mice at 5 
and 27 mo along with 35-mo-old wild-type 
mice. (A–D) Error bars represent SD. Asterisks 
mark values that are signiﬁ  cantly  different 
from wild-type values using a Mann-Whitney 
test. (E) Representative hematoxylin and   eosin–
stained dorsal skin sections of 5- and 27-
mo-old wild-type and Bub3
+/–/Rae1
+/– from 
which the data in C and D were collected. 
  Dermis (d) and adipose layer (a) are indicated. 
Bars, 100 μm.JCB • VOLUME 172 • NUMBER 4 • 2006  534
  compared with MEFs of the other three genotypes (Fig. 6 D). 
At P3, MEF cultures of all four genotypes had comparable 
numbers of cells that were positive for senescence-associated 
(SA) β-galactosidase activity (Fig. 6 E). However, at P5 and P7, 
Bub3
+/–/Rae1
+/– MEFs showed a profound increase in the num-
ber of cells staining positively for SA β-galactosidase in com-
parison with Bub3
+/–, Rae1
+/–, and wild-type MEFs. Consistent 
with these data, the senescence response genes p53, p21, p19, 
and p16 were induced earlier in Bub3
+/–/Rae1
+/– MEFs than 
in Bub3
+/–, Rae1
+/–, and wild-type MEFs (Fig. 7 A). Together, 
these fi  ndings indicate that compound heterozygosity of Bub3 
and Rae1 causes early onset of cellular senescence.
The induction of p53, p21, and p19 indicates that the le-
sion triggering cellular senescence in Bub3/Rae1 double hap-
loinsuffi  cient MEFs activates the p53 DNA damage response 
pathway. To investigate whether activation of the p53 pathway 
might be caused by defective DNA repair, we analyzed the fi  del-
ity of distinct DNA damage repair pathways by measuring cell 
survival and colony formation ability after exposing Bub3
+/–/
Rae1
+/– MEF cultures to various kinds of DNA-damaging 
agents. As shown in Fig. 7 (C–H), the DNA repair capacities of 
Bub3
+/–/Rae1
+/– and wild-type MEFs were very similar, suggest-
ing that increased accumulation of DNA damage is an unlikely 
cause of increased senescence in Bub3
+/–/Rae1
+/– cultures.
The early aging–associated phenotypes that develop in 
Bub3
+/–/Rae1
+/– mice resemble those detected in mice with low 
levels of BubR1 (Baker et al., 2004). However, BubR1
H/H mice 
had a much earlier onset of aging phenotypes than Bub3
+/–/
Rae1
+/– mice. Consistent with this, BubR1 hypomorphic 
MEF cultures contained signifi  cantly higher numbers of SA 
β-  galactosidase–positive cells than Bub3
+/–/Rae1
+/– MEF cul-
tures (Fig. 6 E). In addition, BubR1
H/H MEFs showed a more 
robust activation of the p53 and p16 pathways than Bub3
+/–/
Rae1
+/– MEFs (Fig. 7 B). These data draw a clear correlation 
between the level of induction of senescence response genes 
and the rate of premature aging.
To further test this correlation, we prepared MEFs from 
Mad2 haploinsuffi  cient mice and measured the degree of se-
nescence at P3, P5, and P7. At each passage, the percentage 
of SA β-galactosidase–positive Mad2
+/– MEFs was similar to 
that of wild-type MEFs (Fig. S1 A, available at http://www.
jcb.org/cgi/content/full/jcb.200507081/DC1). Furthermore, at 
each passage, p53, p21, p19, and p16 levels of Mad2
+/– MEFs 
were comparable with those of wild-type MEFs (Fig. S1 B). 
Figure 6.  Early onset of cellular senescence in Bub3/Rae1 
double haploinsufﬁ  cient  MEFs.  (A) Analysis of the percent-
ages of cell death in Bub3
+/–/Rae1
+/– and wild-type MEFs 
cultures by TUNEL assay (n = 3 MEF lines per genotype). 
(B) Percentages of Bub3
+/–/Rae1
+/– and wild-type MEFs that 
are in the early stages of apoptosis (annexin V
+/PI
− cells), in 
the late stages of apoptosis, already dead (annexin V
+/PI
+ 
cells), that undergo nonapoptotic cell death (annexin V
–/PI
+ 
cells), or that are dead (PI
+ cells). We used 3 MEF lines per 
genotype. We note that the differences between Bub3
+/–/
Rae1
+/– and wild-type MEFs were not statistically signiﬁ  cant 
using an unpaired t test. (C and D) Growth curves of wild-
type, Bub3
+/–, Rae1
+/–, and Bub3
+/–/Rae1
+/– MEF cells at P3 
(C) and P7 (D). 1.5 × 10
5 cells of indicated passages were 
seeded in duplicate on day 0 and counted for ﬁ  ve consecu-
tive days. Lines represent three independent MEF lines. Note 
that Bub3
+/–/Rae1
+/– MEF cells have reduced proliferation 
potential at P7, whereas single heterozygous Bub3
+/– and 
Rae1
+/– MEFs do not. (E) Percentages of wild-type, Bub3
+/–, 
Rae1
+/–, BubR1
H/H, and Bub3
+/–/Rae1
+/– MEF cells that 
were positive for SA β-galactosidase activity at the indicated 
passages (n = 3 lines for each genotype at each passage). 
Asterisks in D and E mark values that are signiﬁ  cantly different 
from those of wild-type mice using an unpaired t test. Error 
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Consistent with these fi  ndings, we observed no early aging– 
  related phenotypes in the small cohort of Mad2
+/– mice that we 
followed for a period of 19–27 mo (Fig. S1 C). Chromosome 
counts showed that 18% of Mad2
+/– splenocytes were aneu-
ploid when mice were 5 mo of age (Fig. S1 D). Thus, Mad2 
haploinsuffi   ciency does not promote cellular senescence in 
MEFs and does not seem to trigger aging-related phenotypes in 
mice, although aneuploidy is increased.
Spindle assembly checkpoint 
activity measurements
Our chromosome counts suggested that there is a rather weak 
link between checkpoint dysfunction and the early onset of 
  senescence and aging. To further investigate this issue, we 
  obtained two additional measures for checkpoint activity by 
methods involving live cell imaging. The fi  rst assay is a no-
codazole challenge assay. MEFs carrying various mitotic check-
point gene defects were fi   rst transduced with a retrovirus 
carrying a YFP-tagged H2B gene to allow visualization of chro-
mosomes by fl  uorescent microscopy. We then challenged the 
MEFs with nocodazole and measured the duration of the ensu-
ing checkpoint-dependent mitotic arrest. This duration of arrest 
in mitosis was defi  ned as the interval between nuclear envelope 
breakdown (NEBD; onset of mitosis) and chromatin deconden-
sation (exit from mitosis without cytokinesis). We used the time 
at which 50% of the cells had exited mitosis for comparison. 
Nocodazole-challenged wild-type MEFs typically remained ar-
rested in prometaphase for 7.2 h (Fig. 8 A). However, single 
haploinsuffi  cient MEFs of Bub3 and Rae1 showed a profound 
decrease in their ability to maintain this arrest, with 50% of the 
cells exiting at 3 h. Bub3
+/–/Rae1
+/– MEFs had an even further 
reduction in their ability to sustain arrest, with 50% of the cells 
exiting mitosis at 2.2 h. BubR1
+/H and BubR1
+/– MEFs, which 
express  60 and 30% of normal BubR1 protein, respectively 
(Baker et al., 2004), also had signifi  cant reductions in their abil-
ity to maintain a mitotic arrest, with 50% of the cells exiting at 
5.3 and 3.8 h (Fig. 8 B). BubR1
H/H MEFs ( 10% BubR1) had 
the most profound inability to maintain mitotic arrest, with 50% 
of the cells exiting at 1.1 h. It surprised us that the duration of 
arrest of BubR1
H/H MEFs was substantially shorter than that of 
Bub3
+/–/Rae1
+/– MEFs, because BubR1
H/H MEFs have less se-
vere aneuploidy than Bub3
+/–/Rae1
+/– MEFs (Table II; also see 
Discussion). As an alternative measure for spindle checkpoint 
activity, we measured the accuracy of chromosome segregation 
during mitosis. In essence, we followed YFP-H2B–positive 
MEFs through an unchallenged mitosis by live cell imaging 
and determined the fraction of mitotic cells with chromo-
some  segregation defects. We observed little or no misaligned 
Figure 7. Bub3
+/−/Rae1
+/− MEFs have higher 
levels of SA molecular markers. (A) West-
ern blot analysis of proteins in extracts from 
wild-type, Bub3
+/–, Rae1
+/–, and Bub3
+/–/
Rae1
+/– MEFs at P3, P5, and P7. Blots were 
probed with antibodies against the indicated 
proteins. Note that the induction of senescence 
markers is delayed in Rae1
+/– MEFs; this de-
lay was consistently seen in three independent 
Rae1
+/– MEF lines. (B) Western blots of protein 
extracts from P5 wild-type, Bub3
+/–/Rae1
+/–, 
and BubR1
H/H MEFs probed with the indicated 
antibodies. The results shown in A and B are rep-
resentative for three independently generated 
MEF lines of each genotype. (C–H) Analysis 
of the ﬁ  delity of distinct DNA damage repair 
pathways by measuring cell survival and col-
ony formation ability after exposing early pas-
sage MEFs to various kinds of DNA-damaging 
agents. (C–E) Survival curves of wild-type and 
Bub3
+/−/Rae1
+/− MEFs after DNA damage 
by γ-irradiation (C), UV type B (D), or para-
quat (E). (F–H) Colony-forming assay of wild-
type and Bub3
+/−/Rae1
+/− MEFs after DNA 
damage by γ-irradiation (F), UV type B (G), or 
paraquat (H). Error bars represent SD.JCB • VOLUME 172 • NUMBER 4 • 2006  536
  chromosomes in wild-type, Bub3
+/–, Rae1
+/–, Bub3
+/–/Rae1
+/–, 
and BubR1
H/H metaphases (Table III). However, a relatively large 
proportion of Bub3
+/–/Rae1
+/– and BubR1
H/H anaphases had lag-
ging chromosomes (Table III, Videos 1–3, and Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200507081/DC1). 
The incidence of lagging chromosomes was also increased 
in Bub3
+/– and Rae1
+/– anaphases, but to a lesser extent. 
It should be noted that lagging chromosomes are not necessarily 
a sign of failed mitotic checkpoint signaling because they could 
result from merotelically attached kinetochores that do not acti-
vate the mitotic checkpoint (Cimini et al., 2001). Bub3
+/–/
Rae1
+/– MEFs had not only a somewhat higher percentage of 
anaphases with lagging chromosomes than BubR1
H/H MEFs but 
also a higher percentage of abnormal anaphases with more than 
one lagging chromosome (Table III and Video 3). This may ex-
plain why the spectrum of chromosome losses and gains is 
wider for Bub3
+/–/Rae1
+/– MEFs than for BubR1
H/H MEFs 
  (Table II). Collectively, the aforementioned data confi  rm that 
spindle assembly checkpoint dysfunction and chromosome 
missegregation do not correlate well with cellular senescence 
and aging.
Discussion
In this study, we used mice in which the mitotic checkpoint pro-
teins Bub3 and Rae1 were disrupted individually or in combi-
nation to address whether premature aging is a common 
consequence of mitotic checkpoint gene defects. We found that 
Bub3 and Rae1 single haploinsuffi  cient mice exhibit no signs of 
early aging despite their weakened checkpoint and progressive 
aneuploidy. Conversely, several aging-related phenotypes ap-
pear early in mice that are haploinsuffi  cient for both Bub3 and 
Rae1. However, BubR1 hypomorphic mice age much faster but 
have less aneuploidy than Bub3/Rae1 haploinsuffi  cient mice. 
This suggests that spindle assembly checkpoint dysfunction, 
which leads to the accumulation of aneuploidy, is unlikely to 
cause premature aging in BubR1 and Bub3/Rae1 mutant mice. 
We fi nd that only mitotic checkpoint gene defects that can pro-
voke cellular senescence in MEFs cause the early onset of 
  aging-associated phenotypes in mice, with levels of induction 
of p19, p53, p21, and p16 highly correlating with the rate of 
cellular senescence and aging.
In the study of hypomorphic BubR1 mice (Baker et al., 
2004), it became apparent that as these mice began to show 
signs of premature aging, they also started to accumulate aneu-
ploid splenocytes. This led to the hypothesis that an  euploidy 
might be the primary lesion triggering cellular senescence and 
the process of aging. The use of Bub3 and Rae1 haploinsuffi  -
cient mice allowed for rigorous testing of this hypothesis. 
At 5 mo, BubR1 hypomorphic mice have an aged appearance 
with detectable aneuploidy in 15% of their splenocytes (Baker 
et al., 2004). Age-matched single heterozygous Bub3 and Rae1 
Figure 8.  Spindle assembly checkpoint activity analysis. (A) Analysis of 
mitotic checkpoint activity of wild-type, Bub3
+/–, Rae1
+/–, and Bub3
+/–/
Rae1
+/– MEFs. MEF cultures were challenged with nocodazole, and cells 
undergoing NEBD were marked. We continued to monitor these cells at 
15-min intervals until their chromosomes decondensed. The duration of ar-
rest in mitosis was deﬁ  ned as the interval between NEBD (onset of mitosis) 
and chromatin decondensation (exit from mitosis without cytokinesis). 
The time at which 50% of the cells had exited mitosis has been indicated. 
This time was used as a measure for spindle assembly checkpoint activity. 
(B) Analysis of mitotic checkpoint activity of wild-type, BubR1
+/H, BubR1
+/–, 
and BubR1
H/H MEFs. We note that BubR1
+/H and BubR1
+/– mice have a 
normal lifespan and lack early aging–associated phenotypes (Baker et al., 
2004). Error bars represent SEM.
Table II. Bub3/Rae1 double haploinsufﬁ  cient MEFs develop more severe aneuploidy than BubR1 hypomorphic MEFs
Mitotic MEF 
genotype (n)
Mitotic
ﬁ  gures
inspected
Percent
aneuploid
ﬁ  gures (SD)
Karyotypes with indicated chromosome number Percent
mitotic
ﬁ  gures with
PMSCS (SD)
33 34 36 37 38 39 40 41 42 43 44 45 46 47 49 51 53
Wild type (3)  150 9 (1) 7 136 7 <1
Bub3
+/− (3) 150 19 (2) 1 4 9 121 8 2 2 3 0
Rae1
+/− (3) 150 19 (2) 5 2 6 121 9 1 2 4 0
Bub3
+/−/Rae1
+/− ( 3 ) 1 5 0 4 1  ( 2 ) 16533 1 5 8 8 6 234451211 1 9  ( 3 )
BubR1
H/H (3) 125 36 (6) 5 13 80 20 6 1 15 (3)
Empty spaces mean that there were no karyotypes with the indicated chromosome number. Karyotyping was performed at passage 5.SPINDLE ASSEMBLY CHECKPOINT GENE DEFECTS AND AGING • BAKER ET AL. 537
mice each have 9% aneuploid splenocytes but show no signs of 
early aging. One could argue that this may be the result of hav-
ing aneuploidy that remains below a critical level. Splenocytes 
from 5-mo-old compound Bub3/Rae1 mice have 36% aneu-
ploidy and a wide spectrum of chromosome losses and gains 
(Table I), but these animals show no overt features of aging at 
this age. If aneuploidy alone was a driving force of aging, these 
mice should have shown phenotypes of aging earlier than 
BubR1 hypomorphic mice. It is possible that the degree of an-
euploidy in splenocytes is not representative of the degree pre-
sent in tissues and cell types that develop early aging phenotypes. 
Although we cannot exclude this possibility with our current 
methods for measuring aneuploidy in vivo, the view that aneu-
ploidy does not correlate with aging is further underscored by 
the fi  nding that Bub3
+/–/Rae1
+/– MEFs are more aneuploid than 
BubR1 hypomorphic MEFs but exhibit lower levels of cellular 
senescence. In contrast, in mice with mitotic checkpoint gene 
defects, the rate of aging strongly correlates with the rate of cel-
lular   senescence. The induction of p53, p21, and p19 in both 
BubR1 hypomorphic and combined Bub3/Rae1 haploinsuffi  -
cient cells but not Bub3 and Rae1 single haploinsuffi  cient cells 
suggests that the lesion triggering cellular senescence and aging 
activates the p53 pathway. Like BubR1
H/H MEFs (Baker et al., 
2004), Bub3
+/–/Rae1
+/– MEFs have no detectable defects in 
DNA repair, suggesting that the lesion that triggers p53 activa-
tion is unlikely to be the accumulation of DNA damage or mu-
tations. Various stress signals other than DNA damage are 
known to activate the p53 pathway (Ben-Porath and Weinberg, 
2005; Harris and Levine, 2005), and future experiments will be 
necessary to   determine whether any of these signals might be 
active in BubR1 hypomorphic and Bub3/Rae1 mutant mice.
Rae1, Bub3, and BubR1 have all been implicated in func-
tions outside of the spindle assembly checkpoint. For example, 
Rae1 was originally discovered as a nucleocytoplasmic trans-
port factor that regulates the export of mRNA from the nucleus 
(Brown et al., 1995; Kraemer and Blobel, 1997; Pritchard et al., 
1999). How Rae1 regulates nuclear transport and whether Bub3 
functions also in the transport machinery has not yet been estab-
lished. We found that combined Bub3/Rae1 haploinsuffi  ciency 
does not cause overt defects in global mRNA export or nuclear 
pore complex biogenesis (Fig. S2, available at http://www.jcb.
org/cgi/content/full/jcb.200507081/DC1). However, our experi-
ments by no means represent a comprehensive analysis of the 
transport machinery, and it is certainly possible that Bub3/Rae1 
haploinsuffi  cient cells have subtle traffi  cking defects. A recent 
study has suggested that Bub3 can interact with histone deacetyl-
ases and that, in this context, Bub3 might act to repress gene 
transcription in interphase (Yoon et al., 2004). BubR1 can also 
repress gene transcription in a heterologous DNA-binding 
  context, although not in conjunction with histone deacetylases 
(Yoon et al., 2004). BubR1 also seems to mediate apoptosis of 
cells that exit mitosis without chromosome segregation (Shin 
et al., 2003), and, in yeast, the BubR1 homologue Mad3 and 
Bub3 have both been linked to the accumulation of gross chro-
mosomal rearrangements (Myung et al., 2004). Thus, it is pos-
sible that functions outside of the spindle assembly checkpoint 
are compromised in BubR1 hypomorphic and Bub3/Rae1 hap-
loinsuffi  cient mice and that early onset of aging-related pheno-
types is linked to such defects.
Although BubR1 hypomorphic mice age much faster than 
Bub3/Rae1 mutant mice, both models have a common spectrum 
of age-related phenotypes that is distinctive from that of mouse 
strains in which DNA damage repair or telomere maintenance 
defects cause premature aging (Hasty et al., 2003; Lombard 
et al., 2005). For example, mice with mitotic checkpoint gene 
defects develop cataracts at high incidence, whereas the other 
models do not. Conversely, mice with defects in DNA damage 
repair or telomere maintenance show hematopoietic stem cell 
depletion and glucose intolerance, whereas mice with a weak-
ened mitotic checkpoint do not (unpublished data). This distinc-
tion supports the idea that the lesion that triggers aging in 
BubR1 hypomorphic mice and Bub3/Rae1 mutant mice is dis-
tinct from that of other aging models. This suggestion is further 
supported by the demonstration that DNA damage repair and 
telomere maintenance functions are seemingly intact in Bub3/
Rae1 haploinsuffi   cient mice and BubR1 hypomorphic mice 
(Baker et al., 2004).
In this study, we have used a modifi  ed nocodazole chal-
lenge assay to measure the duration of sustained spindle check-
point activity of MEFs with various mitotic checkpoint gene 
defects. In essence, we treated MEFs with nocodazole and de-
termined how long individual cells remained in mitosis by live 
cell imaging and then used this time as a measure for spindle 
checkpoint activity. We validated our nocodazole challenge as-
say by using a series of MEFs with a graded reduction of BubR1 
protein level. We found that the duration of arrest in mitosis de-
clined as the amount of BubR1 decreased. We found further that 
this time of arrest correlated well with the rate of aneuploidy 
Table III. Chromosome missegregation rates in MEFs with various mitotic checkpoint gene mutations
Genotype (n) Mitotic cells
inspected
Metaphases
with misaligned
chromosomes
Anaphases
with lagging
chromosomes
Anaphases with
indicated number 
of lagging chromosomes
Percent abnormal
anaphases with multiple
lagging chromosomes
0123458
Wild type (6) 114 0 (0%) 3 (2.6%) 111 3 0
Bub3
+/− (5) 152 1 (0.7%) 9 (5.9%) 143 8 1 11
Rae1
+/− (5) 100 0 (0%) 7 (7.0%) 93 7 0
Bub3
+/−/Rae1
+/− (6) 130 0 (0%) 19 (14.6%) 114 10 33111 4 7
BubR1
H/H (6) 149 0 (0%) 18 (12.1%) 131 15 2 1 17
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and chromosome missegregation. However, the fi  nding  that 
Bub3/Rae1 double-insuffi  cient MEFs are more aneuploid than 
BubR1
H/H MEFs (the percentage of aneuploid cells is higher 
and the spectrum of chromosome losses and gains is wider) ap-
pears inconsistent, as we fi  nd that Bub3/Rae1 haploinsuffi  cient 
MEFs sustain their mitotic arrest in nocodazole for twice as 
long as BubR1
H/H MEFs. A possible explanation for this dis-
crepancy is that the nocodazole challenge assay may not pro-
vide a reliable measure for spindle assembly checkpoint activity; 
the reasoning is that the checkpoint functions to protect cells 
against chromosome missegregation rather than against micro-
tubule poisoning. Alternatively, increased aneuploidy in Bub3/
Rae1 haploinsuffi  cient cells might be caused by the dysfunction 
of proteins involved in chromosome segregation but not in the 
spindle assembly checkpoint. Examples of such proteins are 
AdAPC (adenomatous polyposis coli; Kaplan et al., 2001), se-
curin (Jallepalli and Lengauer, 2001), and separase (Waizenegger 
et al., 2002; Chestukhin et al., 2003).
Abnormal numbers of chromosomes, termed aneuploidy, 
is one of the most common properties of cancer cells (Raja-
gopalan and Lengauer, 2004). Because aneuploidy occurs with 
such high frequency, it has been suggested that an  euploidy is an 
essential step in the process of tumorigenesis (Lengauer et al., 
1998). In this study, we have demonstrated that Bub3
+/–, Rae1
+/–, 
and Bub3
+/–/Rae1
+/– mice do not show any differences in both 
the rate of tumor formation and the type of tumor formed in 
comparison with wild-type animals. An earlier cancer suscepti-
bility study on Bub3
+/– mice yielded similar data   (Kalitsis et al., 
2005). That study further showed that even on a p53 or Rb1 het-
erozygous background, Bub3 haploinsuffi  ciency had no signifi  -
cant effect on tumorigenesis. A suggested explanation for these 
fi  ndings was that the degree of impairment of the checkpoint 
machinery was too low to cause substantial aneuploidy   (Kalitsis 
et al., 2005). However, although the aneuploidy in our dou-
ble heterozygous Bub3/Rae1 mice is quite severe at 5 mo, we 
fi  nd no increased susceptibility to lifetime spontaneous tumor 
  development. This result is consistent with our earlier observa-
tion that BubR1 hypomorphic mice are not tumor prone despite 
having severe aneuploidy (Baker et al., 2004). So far, only Mad2 
haploinsuffi  ciency has been shown to increase the risk for spon-
taneous tumors in mice (Michel et al., 2001). However, several 
studies have shown that impaired spindle checkpoint function 
increases the risk for carcinogen-induced tumors. For instance, 
we have shown previously that Rae1
+/– and Bub3
+/–/Rae1
+/– 
mice are susceptible to lung adenoma formation after early 
postnatal treatment with dimethylbenzanthrene (DMBA; Babu 
et al., 2003). Others have shown that BubR1
+/– mice have a sus-
ceptibility to azoxymethane-induced intestinal and lung tumor 
development (Dai et al., 2004), and, consistent with this fi  nding, 
we observed that DMBA-treated BubR1
H/H mice are prone to 
lung tumors (Fig. S3, available at http://www.jcb.org/cgi/ 
content/full/jcb.200507081/DC1). All of these studies illustrate 
an important point that challenging these mice with carcinogenic 
agents introduces cooperating mutations that synergize with 
mitotic checkpoint failure to cause tumorigenesis and that these 
mutations may not occur under normal situations. It seems that 
the identifi  cation of gene mutations that cooperate with spindle 
assembly checkpoint gene alterations in tumorigenesis will be 
important to provide a better understanding of the role of aneu-
ploidy in cancer. The link between spindle assembly checkpoint 
impairment and cancer predisposition is further supported by 
a recent report showing that a high proportion of individuals 
with mosaic variegated an  euploidy (MVA) syndrome carry bi-
allelic mutations in the BubR1 gene (Hanks et al., 2004). MVA 
is a rare recessive disorder that is characterized by severe an-
euploidy and a high risk for neoplasms such as rhabdomyo-
sarcoma, Wilms tumor, and leukemia (Kajii et al., 2001; Plaja 
et al., 2001). Other characteristics of MVA syndrome include 
microcephaly, growth retardation, and eye abnormalities such 
as cataracts. Whether MVA patients with bi-allelic mutations in 
BubR1 develop progeroid features other than growth retarda-
tion and cataracts remains to be established: so far, only four 
patients with BubR1 mutations have been identifi  ed, three of 
which are <3 yr of age.
In a recent study, Kalitsis et al. (2005) confi  rmed that 
MEFs from Bub3 haploinsuffi  cient mice have increased an-
euploidy, but the increase was not as profound as the one we 
previously observed (Babu et al., 2003). The smaller increase 
most likely results from the fact that chromosome counts were 
performed at P3 instead of P5. Furthermore, BubR1
+/− mice 
generated by Wang et al. (2004) typically exhibited spleno-
megaly and extramedullary megakaryopoiesis, but we did not 
detect these phenotypes in our BubR1
+/− and BubR1
H/H mice 
(Baker et al., 2004). It is unclear why that is, but it might be 
the result of the different methods used to create the models 
(enhancer trapping vs. homologous recombination), differences 
in the mouse housing facilities, and/or possible differences in 
genetic background.
Materials and methods
Generation of knockout mice and DMBA treatments
Bub3 and Rae1 heterozygous knockout mice and BubR1 hypomorphic 
mice were generated as described previously (Babu et al., 2003; Baker 
et al., 2004). These mice were derived from 129Sv/E embryonic stem 
cells and maintained on a mixed 129Sv/E × C57BL/6 genetic back-
ground. Mad2
+/– mice were gifts from R. Benezra (Weill Medical College 
of Cornell University, New York, NY; Dobles et al., 2000). All mice were 
housed in a pathogen-free barrier facility for the duration of the study. 
  Experimental procedures involving laboratory mice were reviewed and 
approved by the Institutional Animal Care and Use Committee of the Mayo 
Clinic. Prism software (GraphPad Software, Inc.) was used for the genera-
tion of survival curves and for statistical analysis. DMBA treatments were 
performed as described, except the duration of treatment was 4 mo in-
stead of 5 (Babu et al., 2003).
Karyotype analysis
Metaphase spreads were prepared from splenocytes as described previ-
ously (Babu et al., 2003). The aneuploidy data for Bub3
+/–, Rae1
+/–, and 
Bub3
+/–/Rae1
+/– MEFs presented in Table II were ﬁ  rst published in Babu 
et al. (2003); the data for BubR1
H/H MEFs and mice were ﬁ  rst published in 
Baker et al. (2004).
Collection and analysis of tumors
Moribund mice were killed, and major organs were screened for overt tu-
mors using a dissection microscope. Collected tumors were processed for 
histopathology by standard methods. A chi square or Fisher’s exact test 
was used to compare tumor incidence proportions across the genotypes 
for mice that developed tumors. Board-certiﬁ  ed pathologists assisted in 
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Cataract and body fat analysis
Biweekly, mice were screened for overt cataracts by examining dilated 
eyes with a slit light. At biopsy, cataractous eyes were collected and pro-
cessed by standard methods for histological evaluation. Body fat content 
was measured using a small animal densitometer (Lunar PIXImus Corp.) as 
described previously (Nagy and Clair, 2000). A Mann-Whitney test was 
used for statistics.
Analysis of skin and skeletal muscle
Dorsal skin was dissected, ﬁ  xed in 10% formalin, processed, and embed-
ded in parafﬁ  n. 5-μm cross sections were prepared and stained with he-
matoxylin and eosin using standard procedures. Sections were stained, 
and the thickness of the dermal and adipose layers was calculated using a 
calibrated computer program (Spot Advanced; BioSpot). 40 random mea-
surements were taken for each mouse of each genotype at the indicated 
age (n = 4 males). Histopathology on gastrocnemius muscle was per-
formed as previously described (Kane et al., 2004; O’Cochlain et al., 
2004). A Mann-Whitney test was used for statistics.
Generation and culture of MEFs
MEFs were generated from wild-type Bub3
+/–, Rae1
+/–, or Bub3
+/–/
Rae1
+/– 13.5-d-old embryos as previously described (Babu et al., 2003). 
Growth curves of MEFs were generated as previously described (Baker 
et al., 2004). BubR1
H/H, BubR1
+/–, and BubR1
+/H MEFs were previously 
generated (Baker et al., 2004).
Analysis of cell death, apoptosis, and DNA repair
TUNEL/Hoechst stainings were performed on P5 MEFs according to the 
manufacturer’s protocol (Roche), as were annexin V/PI stainings (BD Bio-
sciences). FACS analysis was performed as previously described (Tran 
et al., 2005). DNA damage survival experiments were performed as 
  described previously (Baker et al., 2004).
SA 𝗃-galactosidase staining
MEFs were stained with an SA β-galactosidase kit according to the manu-
facturer’s protocol (Cell Signal Technology). Nuclei were stained with 
Hoechst for visualization. The percentage of senescent cells is the total 
number of senescent cells divided by the total number of cells.
Western blot analysis
We performed Western blot analysis as previously described (Kasper 
et al., 1999). Antibodies for SA proteins were used at a 1:200 dilution 
(purchased from Santa Cruz Biotechnology, Inc. unless otherwise noted): 
p16 (M-156), p19 (NB200-106; Novus Biologicals), p21 (M-19), and 
p53 (FL-393-G). β-actin was used as a loading control (1:50,000 dilution; 
Sigma-Aldrich).
Time-lapse live microscopy
To allow visualization of chromosomes by ﬂ  uorescent microscopy on live 
cells, we used a retrovirus expressing YFP-tagged H2B that was constructed 
as previously described (Jeganathan et al., 2005). P2 MEFs cells were 
seeded in T25 ﬂ  asks at 50% conﬂ  uence and cultured in DME/10% FBS. 
The next day, these MEFs were grown for 24 h in medium harvested from 
EcoPACK cells that produce pMCSV-puro H2B-YFP virus. 24 h after trans-
duction with pMCSV-H2B-YFP retrovirus, MEFs were seeded in 35-mm 
glass-bottomed culture dishes (MatTek Corporation). The next day, Hepes 
was added to the culture medium at a ﬁ  nal concentration of 20 mM. 4 h 
later, the dish was placed in a heat-controlled stage of a microscope (Axio-
vert 200; Carl Zeiss MicroImaging, Inc.). The temperature was maintained 
at 37°C. CO2 levels were maintained at 10% using a controller (CTI 3700; 
Carl Zeiss MicroImaging, Inc.). For nocodazole challenge experiments, 
nocodazole was added to a ﬁ  nal concentration of 100 ng/ml. During the 
next 30 min, 20–30 cells undergoing NEBD were marked by the use of a 
mark/ﬁ   nd module (AV4 MOD; Carl Zeiss MicroImaging, Inc.). Subse-
quently, time-lapse sequences were captured by using a plan Apo 63× 
NA 1.4 differential interference contrast (D = 0.18) oil objective (Carl 
Zeiss MicroImaging, Inc.) and a camera (AxioCam Hrm; Carl Zeiss Micro-
Imaging, Inc.). The exposure times in nocodazole challenge experiments 
were always 100 ms at 2 × 2 binning. Interframe intervals were 15 min 
except for wild-type, BubR1
+/H, and BubR1
+/– MEFs (intervals were 30 min). 
Imaging WS/20A software (Carl Zeiss MicroImaging, Inc.) was used to 
determine the time of arrest in mitosis of individual cells. The time of arrest 
in mitosis was deﬁ  ned as the interval between NEBD (onset of mitosis) and 
chromatin decondensation (exit from mitosis without cytokinesis). For anal-
ysis of mitotic defects, cells entering mitosis were marked, and images 
were acquired at 2- or 3-min interframe intervals until the completion 
of mitosis.
Indirect immunoﬂ  uorescence and staining for poly(A)
+ RNA
Indirect immunoﬂ   uorescence for mAb414 was performed as described 
previously (Wu et al., 2001), as were stainings for poly(A)
+ RNA (Bastos 
et al., 1996).
Online supplemental material
Fig. S1 shows that Mad2 haploinsufﬁ   ciency does not accelerate cel-
lular senescence or aging. Fig. S2 shows that Bub3
+/−/Rae1
+/− MEFs 
have no overt defects in nuclear pore complex architecture and mRNA 
export. Fig. S3 shows that BubR1
H/H mice are highly susceptible to 
DMBA-induced tumor formation. Fig. S4 shows examples of BubR1
H/H 
anaphases with lagging chromosomes. Video 1 shows a Bub3
+/−/
Rae1
+/− cell undergoing normal mitosis. Videos 2 and 3 show mitotic 
Bub3
+/−/Rae1
+/− cells with one and two lagging chromosomes, re-
spectively. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200507081/DC1.
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